This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Intellicentrics Declares Special Interim Dividend MT
IntelliCentrics Global Holdings Ltd. Announces Special Interim Dividend, Payable on May 3, 2024 CI
Intellicentrics Global Holdings Ltd. Proposes Special Dividend, Payable on or Before May 7, 2024 CI
IntelliCentrics Global Delays Circular Dispatch for Sale of UK Wing MT
IntelliCentrics Global Holdings' Fiscal H1 Loss Widens MT
IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Half Year Ended December 31, 2023 CI
IntelliCentrics Arm to Sell UK Business for $246 Million MT
IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Full Year Ended June 30, 2023 CI
IntelliCentrics Global's July-December 2022 Loss Narrows MT
IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Half Year Ended December 31, 2022 CI
IntelliCentrics Global Holdings Ltd. Appoints Liao Xiaoxin as Independent Non-Executive Director and Member of Audit Committee and Nomination Committee CI
IntelliCentrics Global Holdings Ltd. Announces Executive Changes CI
IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Full Year Ended June 30, 2022 CI
IntelliCentrics’ Innovations Help Drive Advanced Dallas Hospital & Clinics’ Mission of Delivering Leading Edge Medicine and Personalized Patient Care CI
IntelliCentrics enters into Strategic Alliance with Taiwanese Health Insurance Providers CI
Tranche Update on IntelliCentrics Global Holdings Ltd.'s Equity Buyback Plan announced on December 10, 2021. CI
Tranche Update on IntelliCentrics Global Holdings Ltd.'s Equity Buyback Plan announced on October 29, 2021. CI
IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Half Year Ended December 31, 2021 CI
IntelliCentrics Global Projects Wider Loss in Fiscal H1 MT
IntelliCentrics Global Holdings Ltd. Provides Earnings Guidance for the Six Months Ended December 31, 2021 CI
IntelliCentrics Global Holdings Ltd. commences an Equity Buyback Plan for 45,495,215 shares, representing 10% of its issued share capital, under the authorization approved on December 10, 2021. CI
IntelliCentrics Global Holdings Ltd.'s Equity Buyback announced on October 29, 2021, has expired with 2,165,000 shares, representing 0.47% for $1.91 million CI
IntelliCentrics and RepScrubs? Announce Partnership Using ?Trust as a Technology? to Deliver Vendor Compliance that Lowers Costs for Healthcare Facilities CI
Milestone Surgery Center Joins IntelliCentrics?s SEC?URE Ethos to Accelerate Physician Onboarding for Planned Growth CI
IntelliCentrics and EUCARE Announces Strategic Partnership Supporting Delivery of Taiwan?s High-Quality, Integrated Medical Services to the World CI
Chart IntelliCentrics Global Holdings Ltd.
More charts
IntelliCentrics Global Holdings Ltd. operates a technology platform of trust in healthcare known as SECURE. The Company is principally engaged in the operation of a technology platform that verifies data and information. The Company provides the SECURE Ethos technology platform. The SECURE Ethos is a credentialing platform for compliance and security purposes in the healthcare industry. The platform collects, processes and verifies data and information in accordance with the different requirements of locations of care (LoCs). The Company offers two main services on the platform: vendor credentialing solution and medical credentialing solution. It has operations all over the world, including the United Kingdom, Taiwan and Canada. Its subsidiaries include Victos Holding Corp. and IntelliCentrics Zengine (Hong Kong) Company Limited. Victos Holding Corp. is an investment holding company.
More about the company
  1. Stock Market
  2. Equities
  3. 6819 Stock
  4. News IntelliCentrics Global Holdings Ltd.
  5. IntelliCentrics Global's July-December 2022 Loss Narrows